🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main purpose of the study is to assess the safety of 89Zr-panitumumab a...
Status
Withdrawn
Location
Stanford University
Start Date
2021-03-26
Trial ID
NCT04833959
Treatments Being Tested
This study evaluates how well panitumumab-IRDye800 and 89Zr-panitumumab wor...
Status
Completed
Location
Stanford Cancer Institute Palo Alto
Start Date
2019-01-07
Trial ID
NCT03733210
Treatments Being Tested
The goal of this phase I clinical trial is to evaluate the usefulness of an...
Status
Recruiting
Location
Vanderbilt University/Ingram Cancer Center
Start Date
2023-05-09
Trial ID
NCT05747625
The purpose of this study is to determine the diagnostic utility of 89Zr-pa...
Status
Withdrawn
Location
Stanford Cancer Institute
Start Date
2026-06
Trial ID
NCT05423197
Treatments Being Tested
This clinical study will investigate the utility of PET imaging with \[89Zr...
Status
Withdrawn
Location
Multiple Locations
Start Date
2019-03-14
Trial ID
NCT03764137
Treatments Being Tested
This pilot clinical study will investigate if Zirconium-89 (89Zr) panitumum...
Status
Recruiting
Location
UAB
Start Date
2023-02-20
Trial ID
NCT05183048
Treatments Being Tested